Pharma Nord is one of Europe’s largest manufacturers of preventive dietary supplements and herbal remedies. The company develops, manufactures and markets scientifically well founded dietary supplements, herbal remedies and medical drugs based on optimal bio-availability, safety and documentation.

Pharma Nord’s research database contains more than 8,000 scientific studies - including a large number of studies conducted with Pharma Nord’s own preparations. The database is the cornerstone of the entire product development.

With its production facilities and company head quarters located in Denmark, Pharma Nord has a large operational field. Pharma Nord’s products are represented in Europe, the Middle East and in the rapidly expanding markets of Asia, Russia and the United States, through 25 daughter companies and 20 business partners.
Pharma Nord is a privately owned limited company.



Pharma Nord manufactures dietary supplements and herbal remedies in Denmark and is subject to the restrictive Danish laws. Because our legislation is highly respected by markets abroad, Pharma Nord has chosen to meet the increased demand for its products by expanding its Danish production facilities, instead of moving part of its production to other countries. A new plant with production and storage facilities is currently being built in Vojens, 50 kilometres north of the Danish-German border. With this expansion, Pharma Nord will be able to triple its current production capacity, ensuring optimal conditions for future growth and development.



Pharma Nord’s products have become a well-known brand in many countries, particularly because of the characteristic design with its well-known golden mortar and its "peep-hole" to the products inside. Consumers, retailers and health professionals associate the Pharma Nord brand with thorough research and a high level of bio-availability and safety. These virtues are what make Pharma Nord’s preparations viable in a market that is often ruled by trends. In fact, this is what prompted the international Superbrand Council to nominate Pharma Nord "Superbrand 2007" within the Business-to-Consumer market.



Pharma Nord and several other branch colleagues have established Nutraceutical Industry (NI), an association of leading nutraceutical suppliers. The primary task of NI is to bridge the gap between the two sharply separated sectors for pharmaceutical drugs and food, respectively. Sven Moesgaard, Pharma Nord's director of technical affairs, chairs Nutraceutical Industry.


Pharma Nord was founded in 1982 by the two current owners, Eli Wallin and Sven Moesgaard, who established an import of a British selenium product. Soon after, the product was developed additionally and ended up as the product known as Selenium®+Zinc Pharma Nord, which is still a cornerstone of the product range.

The underlying idea of Pharma Nord was to compensate for the shortcomings of the modern diet by means of dietary supplements with high bio-availability and a documented effect. Selenoium®+Zinc Pharma Nord successfully embedded this philosophy in a single product and paved the road for the first daughter companies that were established in Sweden, England and Finland

Over the years, Pharma Nord has earned a reputation as an innovative and visionary player on the nutraceutical market on several occasions. Phama Nord was the first company to introduce coenzyme Q10 to the European market. Its product Bio-Quinone Q10 was launched in 1990 and has grown to become one of the leading Q10 products worldwide. This is just one of many examples showing how Pharma Nord has spearheaded the market by channelling the most up to date knowledge into their products.

Pharma Nords products are currently retailed in more than 45 countries. Approximately 85% of the companys products are registered as medical drugs of some kind in one or several countries. This is the reason why all products without exception are manufactured in accordance with the current GMP guidelines (Good Manufacturing Practice).


The combination of documented products and exclusive retail through retailers and pharmacies has ensured Pharma Nord notable success and worldwide recognition. Over the years, Pharma Nord has received a number of honorary awards from branch and retail organisations on the different markets.


Most recently, Pharma Nord received the following awards:

  • Oeuvre Award (Lifetime Achievement Award)
  • Superbrand of the Year on the B2C market (nominated)
  • Product of the Year
  • Most informative campaign

Product of the Year - Holland


CLA-T - The year product in Bulgaria

CLA-T - The year product in Portugal

Customer Service

Office hours:
09.00 - 17.30
Friday 09.00 - 16.30
Phone: +353(0) 1 899 1650


 Pharma Nord - Unit 289 - Blanchardstown Corporate Park 2 - Ballycoolin - Dublin 15 - Ireland